Literature DB >> 7679560

Histamine release by morphine and diamorphine in man.

D E Withington1, J A Patrick, F Reynolds.   

Abstract

Intravenous morphine and diamorphine are routinely used for postoperative analgesia but the relative histamine releasing abilities of these drugs have not been compared in man. Thirty-eight patients were randomly allocated to receive morphine (0.16 mg.kg-1) or diamorphine (0.08 mg.kg-1) after abdominal surgery. Blood samples for histamine were taken before, and at timed intervals after, opioid administration and analysed by an isotopic radioenzymatic technique. Haemodynamic parameters and pain scores were recorded before and after analgesic administration, and a series of eight basophil histamine release studies was also performed. Significant histamine release (plasma concentration > 2 ng.ml-1 or rise of > 700% baseline) occurred in 23.5% of the morphine group and 21.1% of the diamorphine group. Histamine was released earlier in those receiving diamorphine, but no significant change in haemodynamic parameters occurred, and no histamine release was demonstrated in the basophil histamine release studies. These findings suggest that morphine and diamorphine release histamine from mast cells rather than basophils.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679560     DOI: 10.1111/j.1365-2044.1993.tb06785.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  10 in total

Review 1.  Immunotoxicology: role in the safety assessment of drugs.

Authors:  Jacques Descotes
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  An overview of chronic urticaria.

Authors:  Vincent S Beltrani
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

Review 3.  Intravenous vasodilator therapy in congestive heart failure.

Authors:  Kourosh Moazemi; Jatinder S Chana; Anna Marie Willard; Abraham G Kocheril
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

4.  Eosinophilic pneumonia associated with heroin inhalation: a case report.

Authors:  Apostolos Tsapas; Konstantinos Paletas; Efthymia Vlachaki; Eleni Bekiari; Constantine Spanos; Dimitrios Economidis
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 5.  The effects of opioids on the lung.

Authors:  Joshua B Radke; Kelly P Owen; Mark E Sutter; Jonathan B Ford; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

6.  Basophil activation tests: a diagnostic break-through in opiate allergy.

Authors:  Astrid Uyttebroek; Athina Van Gasse; Vito Sabato; Chris Bridts; Didier Ebo
Journal:  Allergy Asthma Immunol Res       Date:  2014-06-18       Impact factor: 5.764

7.  Medical diagnoses associated with substance dependence among inpatients at a large urban hospital.

Authors:  Humberto Choi; Anne Krantz; Jennifer Smith; William Trick
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

8.  NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation.

Authors:  Le Shen; Weijia Wang; Siyu Li; Jing Qin; Yuguang Huang
Journal:  Mol Brain       Date:  2018-06-28       Impact factor: 4.041

Review 9.  [Asthma and heroin use].

Authors:  Michel Underner; Jean Perriot; Gérard Peiffer; Nematollah Jaafari
Journal:  Presse Med       Date:  2017-07-20       Impact factor: 1.228

Review 10.  [Asthma and cannabis, cocaine or heroin use].

Authors:  M Underner; G Peiffer; J Perriot; N Jaafari
Journal:  Rev Mal Respir       Date:  2020-07-08       Impact factor: 0.622

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.